Prostate cancer — all decisions

The Board denied an earlier effective date for the award of a total disability rating based on individual unemployability due to service-connected disabilities (TDIU) prior to July 2, 2023.

The Board granted a 40 percent evaluation for prostate cancer residuals from January 29, 2014 to August 12, 2021.

The Board granted service connection for ischemic heart disease, prostate cancer, and bone cancer as due to herbicide exposure under the PACT Act. The claims for the heart disability and prostate cancer prior to August 10, 2022, were remanded.

The Board granted service connection for prostate cancer and residuals, finding that the Veteran's condition was at least as likely as not caused by in-service exposure to contaminated water at Camp Lejeune.

The Board granted an earlier effective date of August 10, 2022, for the grant of service connection for prostate cancer with residual urinary incontinence and erectile dysfunction under the PACT Act. The claims for an earlier effective date on a basis other than the PACT Act were remanded.

The Board remands the claims for service connection for prostate and bone cancer to correct pre-decisional duty to assist errors.

The Board denied service connection for colon cancer, skin cancer, and prostate cancer. The Veteran was granted a 20% rating for right knee osteoarthritis status post meniscectomy with instability or subluxation and a 10% rating for a right knee scar.

The Board denied a compensable rating for the Veteran's bilateral hearing loss and remanded the claim for service connection for prostate cancer due to potential toxic exposures.

The Board granted service connection for diabetes mellitus type II, hypertension, hypothyroidism, prostate cancer, sleep apnea secondary to service-connected diabetes mellitus, tinea pedis, and lumbar spondylosis.

The Board dismissed the veteran's appeal for service connection for PTSD and prostate cancer as an improper attempt to file a Board Appeal request in response to a Board decision.

The Board denied a rating in excess of 50 percent from May 15, 2024, for migraine headaches as the Veteran is already receiving the maximum schedular rating and referral for extraschedular consideration was not warranted.

The Board granted a disability rating of 60 percent for prostate cancer residuals, characterized by urinary incontinence and denied an initial compensable rating for hypertension.

The Board remands the claim for service connection for prostate cancer to correct a pre-decisional duty-to-assist error related to toxic exposure risk activities (TERA) at Camp Lejeune and other exposures as a Mortarman.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of in-service exposure to herbicides and that the Veteran's prostate cancer is not related to his military service.

The Board remands the claim for service connection of the cause of death to obtain a complete TERA memorandum and a VA examination opinion.

The Board granted service connection for adjustment disorder with depressed mood and a headache disability, as secondary to the Veteran's service-connected prostate cancer residuals. The Board also granted an increased rating of 60 percent for prostate cancer residuals with voiding dysfunction effective September 29, 2023.

The Board remands the claims for service connection for enlarged prostate, prostate cancer, and a skin disability due to missing records from the Veteran's Naval Reserve Service and Social Security Administration.

The Board granted service connection for diabetes mellitus, type II and prostate cancer residuals under the PACT Act but denied a compensable rating for hypertension.

The Board remands the claim for a retrospective VA medical opinion to determine if the Veteran's Parkinson disease, prostate cancer, or OSA are related to his service.

The Board remands the Veteran's claim for service connection for prostate cancer to cure pre-decisional duty to assist errors and obtain a TERA opinion, an ionizing radiation exposure development, and a direct service connection opinion.